These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25661653)
21. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer. Huang KT; Dobrovic A; Fox SB Breast Cancer Res Treat; 2010 Dec; 124(3):853-6. PubMed ID: 20680678 [TBL] [Abstract][Full Text] [Related]
22. The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer. Liu X; Zurlo G; Zhang Q Adv Exp Med Biol; 2020; 1217():173-186. PubMed ID: 31898228 [TBL] [Abstract][Full Text] [Related]
23. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), ElonginBC, and Cullin 5: insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases. Thomas JC; Matak-Vinkovic D; Van Molle I; Ciulli A Biochemistry; 2013 Aug; 52(31):5236-46. PubMed ID: 23837592 [TBL] [Abstract][Full Text] [Related]
24. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Pause A; Peterson B; Schaffar G; Stearman R; Klausner RD Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9533-8. PubMed ID: 10449727 [TBL] [Abstract][Full Text] [Related]
25. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Paltoglou S; Roberts BJ Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177 [TBL] [Abstract][Full Text] [Related]
26. BC-box protein domain-related mechanism for VHL protein degradation. Pozzebon ME; Varadaraj A; Mattoscio D; Jaffray EG; Miccolo C; Galimberti V; Tommasino M; Hay RT; Chiocca S Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18168-73. PubMed ID: 24145437 [TBL] [Abstract][Full Text] [Related]
27. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Schoenfeld AR; Davidowitz EJ; Burk RD Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011 [TBL] [Abstract][Full Text] [Related]
28. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Stebbins CE; Kaelin WG; Pavletich NP Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047 [TBL] [Abstract][Full Text] [Related]
29. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529 [TBL] [Abstract][Full Text] [Related]
30. Proteomic dissection of the von Hippel-Lindau (VHL) interactome. Lai Y; Song M; Hakala K; Weintraub ST; Shiio Y J Proteome Res; 2011 Nov; 10(11):5175-82. PubMed ID: 21942715 [TBL] [Abstract][Full Text] [Related]
31. DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase. Heir P; Sufan RI; Greer SN; Poon BP; Lee JE; Ohh M Mol Cell Biol; 2013 Apr; 33(8):1621-31. PubMed ID: 23401859 [TBL] [Abstract][Full Text] [Related]
32. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Kamura T; Conrad MN; Yan Q; Conaway RC; Conaway JW Genes Dev; 1999 Nov; 13(22):2928-33. PubMed ID: 10579999 [TBL] [Abstract][Full Text] [Related]
33. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940 [TBL] [Abstract][Full Text] [Related]
34. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide. Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595 [TBL] [Abstract][Full Text] [Related]